Integrated Analyses of Copy Number Variations and Gene Expression in Lung Adenocarcinoma
暂无分享,去创建一个
Chuhsing Kate Hsiao | Tzu-Pin Lu | Eric Y. Chuang | Liang-Chuan Lai | Mong-Hsun Tsai | C. K. Hsiao | Jang-Ming Lee | E. Chuang | M. Tsai | L. Lai | T. Lu | Chung-Ping Hsu | Pei-Chun Chen | Pei-Chun Chen | Chung-Ping Hsu | Jang-Ming Lee
[1] J. Testa,et al. Chromosomal imbalances in human lung cancer , 2002, Oncogene.
[2] John Quackenbush,et al. Genesis: cluster analysis of microarray data , 2002, Bioinform..
[3] Y. Mechulam,et al. Eukaryotic and archaeal translation initiation factor 2: A heterotrimeric tRNA carrier , 2010, FEBS letters.
[4] J. Pouysségur,et al. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.
[5] Y. Jeon,et al. High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] William Pao,et al. EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression. , 2008, The Journal of molecular diagnostics : JMD.
[7] Y. Shu,et al. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[8] Holger Sültmann,et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. , 2009, Lung cancer.
[9] I Petersen,et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer , 2008, Oncogene.
[10] Chris Sander,et al. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors , 2009, Oncogene.
[11] Yuri Kotliarov,et al. Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. , 2009, Cancer research.
[12] Wei-Guo Zhu,et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. , 2003, Human molecular genetics.
[13] K. Takeuchi,et al. EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR‐targeting tyrosine kinase inhibitors , 2010, The FEBS journal.
[14] Yi Zhang,et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.
[15] Igor Jurisica,et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] V. Papadimitrakopoulou,et al. The Akt/mTOR and mitogen-activated protein kinase pathways in lung cancer therapy. , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] Chi-Ying F. Huang,et al. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. , 2007, Lung cancer.
[18] Nam Huh,et al. Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression , 2008, Clinical Cancer Research.
[19] A. Hartmann,et al. (www.interscience.wiley.com) DOI: 10.1002/path.2039 , 2006 .
[20] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[21] Jianhui Xie,et al. Negative role of trihydrophobin 1 in breast cancer growth and migration , 2010, Cancer science.
[22] P. Park,et al. Discovering statistically significant pathways in expression profiling studies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Testa,et al. Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. , 1992, Cancer research.
[24] Sharon R Grossman,et al. Integrating common and rare genetic variation in diverse human populations , 2010, Nature.
[25] H. Sasaki,et al. PIK3CA gene amplification in Japanese non-small cell lung cancer. , 2007, Lung cancer.
[26] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[27] Adam M. Gustafson,et al. A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. , 2011, Lung cancer.
[28] Derek Y. Chiang,et al. Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.
[29] A. Bout,et al. IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using ‘cracked’ adenoproducer cells , 1998, Gene Therapy.
[30] F. Cappuzzo,et al. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer , 2009, Oncogene.
[31] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[32] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[33] John D. Minna,et al. Deregulated EGFR Signaling during Lung Cancer Progression: Mutations, Amplicons, and Autocrine Loops , 2008, Cancer Prevention Research.
[34] K. Luh,et al. Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. , 1990, Anticancer research.
[35] P. Hartel,et al. Del(5q) Is Associated With Clinical and Histological Parameters in Small Cell Neuroendocrine Lung Carcinoma , 2008, International journal of surgical pathology.
[36] N. Kikuchi,et al. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance , 2010, Respiratory research.
[37] Huachen Gan,et al. Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration* , 2009, Journal of Biological Chemistry.
[38] M. Ringnér,et al. Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.
[39] S. Wacholder,et al. Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.
[40] Federico Bussolino,et al. Integrin signaling and lung cancer , 2010, Cell adhesion & migration.
[41] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[42] G. Parmigiani,et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.
[43] W. Hahn,et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. , 2009, Molecular cell.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] 加藤 達哉. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis , 2005 .
[46] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] D. Cleveland,et al. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.
[48] Chi-Ying F. Huang,et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme , 2007, BMC Genomics.
[49] Wim Timens,et al. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. , 2009, Lung cancer.
[50] W. Gerald,et al. Identification of DOK genes as lung tumor suppressors , 2010, Nature Genetics.
[51] F. Siannis,et al. Somatic EGFR Mutation and Gene Copy Gain as Predictive Biomarkers for Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.
[52] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[53] T. Godfrey,et al. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer , 2008, Nucleic acids research.
[54] Chuhsing Kate Hsiao,et al. Identification of a Novel Biomarker, SEMA5A, for Non–Small Cell Lung Carcinoma in Nonsmoking Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.